期刊文献+

肿瘤标记物CA_(125)、CA_(153)、CA_(199)与CEA在肺癌诊断中的意义 被引量:9

TUMOR MARKER CA_(125) 、 CA_(153) 、 CA_(199) AND CEA IN LUNG CANCER
下载PDF
导出
摘要 目的 :研究四种肿瘤标记物CA12 5、CA153 、CA199与CEA在肺癌诊断中的意义 ,并以常见的几种呼吸道炎症性疾病 (RIDs)作为对照。结果 :肺癌患者CA12 5、CA153 、CA199及CEA水平均显著高于RIDs患者 (P <0 .0 0 1) ,而CA12 5、CA153 、CA199及CEA水平在肺癌的三种组织学类型和各期肺癌中并显著性差异 (P >0 .0 5 )。采有四项指标的平均值作为标准 ,虽然并不能显著提高诊断的灵敏度 (P >0 .0 5 ) ,但可显著提高诊断的特异性 (P <0 .0 5或 0 .0 1)。结论 :CA12 5、CA153 、CA199及CEA可作为肺癌的标记物 。 Four tumor markers,CA 125 ,CA 153 ,CA 199 and CEA are studied for their relations with lung cancer,using Respiratory Inflammatory Diseases,RIDs (bronchitis,bronchiectasis and pneumonia)as control.The result shows that the serum levels of CA 125 ,CA 153 ,CA 199 and CEA are significantly higher in the patients with lung cancer than in those with RIDs(P<0.001).There are not significant differences of the serum level of CA 125 ,CA 153 ,CA 199 and in different tissular types of lung cancer and at different phases of lung cancer (P>0.05).The mean value of the four markers is used for a new standard for judging lung cancer.The sensitivity is not significantly higher,but the specificity is significantly lifted(P<0.05 or 0.01).It seems that CA 125 ,CA 153 ,CA 199 and CEA can be useful markers for lung cancer,and that the detection of the four markers can play assistant role in the judgement of lung cancer.
作者 谢汉华
出处 《中国现代医学杂志》 CAS CSCD 2001年第1期45-46,共2页 China Journal of Modern Medicine
关键词 肿瘤标记物 肺癌 呼吸道炎症性疾病 诊断 Tumor Markers Lung Cancer Respiratory Inflammatory Diseases(RIDs)
  • 相关文献

参考文献8

  • 1Piardo AL,Diez M,Torres A,et al.Analysis of the prognostic significance of cytosolic determination of CA125 tumor- associated antigen, carinoemryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma[].Cancer.1996
  • 2Fujita J,Dobashi N,Ohtsuki Y,et al.Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in nonsmall-cell lung cancer celllines[].British Journal of Cancer.1999
  • 3Diez M,Pollan M,Maestro ML,et al.oncordance between serum and cytosolic levels of CEA, CA125 and SCC antigens in patients with non-small-cell lung cancer[].Anticancer Research.1995
  • 4Diez M,Torres A,Maestro ML,et al.Predictation of survival and recurrene by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer[].British Journal of Cancer.1996
  • 5Niklinski J,Furman M,Laudanski J,et al.Prognostic value of pretreatment CEA, SCC- Ag and CA19 - 9 levels in sera of patients with non-small cell lung cancer[].European Journal of Cancer Prevention.1992
  • 6Midoue M,Rouaud P,Salama G,et al.Evaluation of seven tumor markers in pleural fluid for the diagnosis of malignant effusions[].British Journal of Cancer.1999
  • 7Kimura Y,Fujii T,Hamamoto K,et al.Serum CA125 level is a good prognostic indicator in lung cancer[].British Journal of Cancer.1990
  • 8Nisman B,Amir G,Lafair J,et al.Prognostic value of CYFRA211, TPS and CEA in different histological types of non- small cell lung cancer[].Anticancer Research.1999

同被引文献41

  • 1李健,刘雄英,陈瑞娥.联合检测血清CA153 CA125 CA199在乳腺癌早期诊断中的价值[J].实用医技杂志,2008,15(13):1696-1698. 被引量:12
  • 2张哲民.联合检测血清CYFRA21-1、CA153及NSE在肺癌诊治中的临床意义[J].中国癌症杂志,2005,15(6):566-568. 被引量:10
  • 3陈智周.肿瘤相关抗原CA-50放免分析[J].中国医学科学报,1988,10(4):262-265.
  • 4李留树 何长青 张效功.癌胚抗原测定在良恶性胸水鉴别诊断中的价值[J].癌症,1986,5(1):55-55.
  • 5黄振符.放射免疫分析在医学中的应用:第1版[M].北京:原子能出版社,1991.312.
  • 6[2]Paweletz CP,Gilespie JW,Ornstein DK,et al.Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip[J].Drug Dev Res,2000,49(1):34-42.
  • 7[3]von Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection coupled with proteinChip array technologies:applications in cancer research[J].Biotechniques,2000,29(5):1066-1070.
  • 8Lodde M, mian C, pycha A, et al.Immunocyt for the detection of trarksitional cell cancer of the urinary tract. J Urol, 1999; 161 : 150-154.
  • 9Von Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection coupled with proteinChip array technologies:applications in cancer research[J].Biotechniques,2000,29(5):1066 ~ 1070.
  • 10Chapman K.The Proteinchip Biomarker System from Ciphergen Biosystems:a novel proteomics platform for rapid biomarker discovery and validation[J].Biochem soc Trans,2002,30 (2):82 ~ 7.

引证文献9

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部